U.S. Water Utilities Stock News

NYSE:TREX
NYSE:TREXBuilding

Will Fire-Code-Compliant Trex Refuge Decking Redefine Trex Company's (TREX) Innovation-Led Market Opportunity Narrative?

Earlier this week, Trex Company launched Trex Refuge, an ignition-resistant cellular PVC decking line engineered for use in fire-prone and Wildland-Urban Interface regions, meeting ASTM E84 Class A Flame Spread and IWUIC ASTM E2768 ignition-resistance standards. The product’s focus on advanced fire performance, code compliance and a 50-year Limited Residential Warranty highlights how Trex is targeting safety-critical applications within outdoor living. Next, we’ll examine how this...
NasdaqGS:RVMD
NasdaqGS:RVMDBiotechs

Is Revolution Medicines (RVMD) Share Price Justified After Strong Multi Year Rally?

If you are wondering whether Revolution Medicines at around US$120 per share reflects its real worth, you are not alone. This article is designed to help you frame that question clearly. The stock closed at US$120.28 recently, with returns of 1.4% over 7 days, 52.7% over 30 days, 52.2% year to date, 198.5% over 1 year and 337.1% over 3 years, which naturally raises questions about how expectations and risk are being priced in. Recent news flow around Revolution Medicines has focused on its...
NasdaqGS:CGON
NasdaqGS:CGONBiotechs

Assessing CG Oncology (CGON) Valuation After Accelerated PIVOT-006 Phase 3 Trial Timeline

CG Oncology (CGON) is back in focus after accelerating the topline data timeline for its Phase 3 PIVOT-006 trial, the first randomized study for intermediate-risk non muscle invasive bladder cancer patients. See our latest analysis for CG Oncology. The accelerated PIVOT-006 timeline sits against a strong recent run, with a 30 day share price return of 40.23% and a 1 year total shareholder return of 88.20%, suggesting momentum has been building around the story. If CG Oncology’s progress has...
NasdaqGS:TIGO
NasdaqGS:TIGOWireless Telecom

Millicom (TIGO) Is Up 17.1% After UBS Upgrade on Latin America Expansion Ambitions

Earlier this week, UBS analyst Leonardo Olmos upgraded Millicom International Cellular (TIGO) to a buy rating, citing increased confidence in the company’s growth outlook as it expands telecom services across Latin America and pursues acquisitions in Ecuador and Uruguay. This shift in analyst sentiment highlights how Millicom’s regional expansion and service diversification are increasingly shaping market perceptions of its longer-term prospects. We’ll now examine how UBS’s renewed...